Glutathione–ROS pathway activation by probiotic B240 augments macrophage response to influenza
Frontiers in Cellular and Infection Microbiology · 2025
DOI: 10.3389/fcimb.2025.1697559 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2025. Verfasst von Zhen Ye und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory and Critical Care Medicine, Tianjin Chest Hospital, Tianjin, China. Hauptthemen laut MEDLINE: Macrophages, Glutathione, Influenza A Virus, H1N1 Subtype, Orthomyxoviridae Infections. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Early outcomes of influenza−induced lung injury depend on the rapid activation of the macrophage–type I interferon (IFN) axis, a process that requires tightly regulated glutathione–reactive oxygen species (GSH–ROS) buffering.
Objective
The aim of this study was to determine whether oral Lactobacillus pentosus B240 amplifies the macrophage–IFN response by pre−modulating the GSH–ROS pathway, thereby enhancing innate immunity against the H1N1 virus.
Methods
The public dataset GSE43764 (48 Agilent one−color microarrays) was re−analyzed using ComBat batch correction, limma differential analysis, gene set variation analysis (GSVA) functional scoring, weighted gene co-expression network analysis (WGCNA) co−expression, CIBERSORTx deconvolution, and mixed−effects modeling; all statistics were Benjamini–Hochberg adjusted.
Results
In uninfected mice, pulmonary Gclc was significantly upregulated in the B240 group ( p adj < 0.05) and overall GSH–ROS and Nrf2 GSVA scores were higher than controls; after the viral challenge, GSH–ROS, Nrf2, macrophage activation, and type I IFN GSVA scores showed significant interactions from 1 to 6 days ( q < 0.05). At 1 dpi, B240+CA04 versus Saline+CA04 had 418 upregulated and 289 downregulated genes ( p adj < 0.05, |log 2 FC| ≥ 0.58), dominated by macrophage markers and ISGs. Gclc and Nqo1 were elevated at 1–3 days ( p < 0.05), and Adgre1 and Rsad2 were elevated at 1–6 days ( p < 0.01). The WGCNA red module (312 genes) correlated most strongly with GSH–ROS GSVA and macrophage abundance ( q < 0.05); GSH–ROS core genes (Gclc and Nqo1) and macrophage–IFN genes (Adgre1, Mx1, and Rsad2) were co−expressed (Pearson r > 0.2, FDR < 0.05). Enrichment covered viral response, type I IFN, RIG−I−like, Toll−like, NOD−like, and JAK−STAT antiviral pathways, plus GSH metabolism, oxidative stress, and macrophage activation (all q < 0.05). CIBERSORTx showed macrophage abundance and the M1/M2 index remained higher at 1, 3, and 6 dpi with B240, with three−way interaction estimates of 0.28 and 0.59 ( q = 0.002). Single−sample analysis revealed stronger GSH–ROS versus macrophage–ISG correlation in B240 ( r = 0.81, q = 0.001) than control ( r = 0.53, q = 0.008); Fisher z p adj = 0.015. Integrative network nodes had Spearman ρ 0.58–0.72 ( q < 0.05), confirming oxidative–IFN coupling.
Conclusions
B240 elevates baseline GSH–ROS thresholds and reshapes a red co−expression module, synchronously amplifying macrophage infiltration and type I IFN feedback, thereby strengthening early innate responses to H1N1 infection and suggesting nutritional–immunological prophylaxis for high−risk respiratory viral exposure.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Respiratory and Critical Care Medicine, Tianjin Chest Hospital, Tianjin, China.
Zitieren
APA
Ye, Z., & Zhang, Y. (2025). Glutathione–ROS pathway activation by probiotic B240 augments macrophage response to influenza. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2025.1697559
Vancouver
Ye Z, Zhang Y. Glutathione–ROS pathway activation by probiotic B240 augments macrophage response to influenza. Frontiers in Cellular and Infection Microbiology. 2025. doi:10.3389/fcimb.2025.1697559
BibTeX
@article{Ye2025,
author = {Ye, Zhen and Zhang, Ying},
title = {Glutathione–ROS pathway activation by probiotic B240 augments macrophage response to influenza},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2025},
doi = {10.3389/fcimb.2025.1697559}
}
EUVIMED